CAS RN: 83732-56-3
[1,4′-bipiperidine]-4′-carboxamide dihydrochloride
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251120
100mg / 250mg / 1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 83732-56-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
83732-56-3 / 4-piperidin-1-ylpiperidine-4-carboxamide;dihydrochloride
Standard CAS: 83732-56-3
Multi CAS: Yes
Basic Information
copy
CAS
83732-56-3 copy
Multi CAS
Yes copy
Molecular Formula
C11H23CL2N3O copy
Molecular Weight
284.220000 copy
Exact Mass
283.121818 copy
InChI
InChI=1S/C11H21N3O.2ClH/c12-10(15)11(4-6-13-7-5-11)14-8-2-1-3-9-14;;/h13H,1-9H2,(H2,12,15);2*1H copy
InChIKey
WXEPVBJQEMWWQF-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Fraction Csp3
0.91 copy
Rotatable bonds
2 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
73.95 copy
TPSA
58.36 copy
LogP / Solubility
WLOGP
0.92 copy
MLOGP
0.82 copy
XLogP3
0.92 copy
Consensus LogP
0.89 copy
Log S (ESOL)
-2.05 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.56 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.51 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.8 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy